Bicara Therapeutics BCAX Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Bicara Therapeutics's preferred stock, shares outstanding?
- Bicara Therapeutics (BCAX) reported preferred stock, shares outstanding of $0 in Q1 2026.